Jay M. Short
Co-Founder, CEO & ChairmanDr. Jay M. Short, Ph.D. Short is Scientific & clinical advisor of Lassogen, Inc. Dr. Jay M. Short, Ph.D., is Advisor of Primrose Bio, Inc. He serves as the Chairman and Chief Executive Officer of BioAtla, LLC. since March 2007. He is the Co-Founder of BioAtla, Inc. in March 2007. He serves as an Advisor at SG Biofuels, Inc. He is an advisor and Director to Biotech Investment Group.He served as President of BioAtla, LLC. He is Founder and Director of Capia IP. He is Founder of VivaMab. He also serves as an advisor to City National Bank, UCSD’s Division of Biology, Genalyte, San Diego Science Festival. He served as an Advisor at Thomas, McNerney & Partners. He focused on biotechnology. He founded Verenium Corporation (formerly Diversa Corporation) and served as its Chief Technology Officer since September 1994, where he served in multiple roles over his many years tenure, which concluded in 2005. He served as the Chief Executive Officer of Verenium Corporation from February 1999 to October 7, 2005 and President from June 1998 to October 7, 2005. He led Verenium in raising a combined 500 million by leading the largest biotechnology IPO at the time and establishing partnerships and joint ventures with best-class companies including Novartis, Syngenta, Dow Chemical, Dupont, Bunge, Danisco, GSK, Merck and Aventis. He founded E.O. Wilson Biodiversity foundation in October 2005 and was its President and Chairman from October 2005 to July 2008. He served as the Chief Executive Officer at Ciris Energy, Inc. until August 16, 2013. He had been the Chairman of Ciris Energy, Inc. since August 16, 2013. He served at biotechnology companies Stratacyte Inc. as President and also served as Vice President of Research and Development and Operations for Stratagene Cloning Systems both molecular biology companies from September 1985 to September 1994. He serves as a Member of the Corporate Advisory Board at Molecular Response, LLC. He serves as a Director of BioDuro and Femta Pharmaceuticals. He serves as a Director of LLC. He was a Director at Invitrogen From 1994 to 2008. He is a Director of Taxon Biosciences. He serves on the U.S. National Research Council panel for Chemical Science and Technology at the National Institute of Standards and Technology and numerous other governmental, grant and journal review boards. He served as a Lead Independent Director of Senomyx Inc. since May 2008 until May 11, 2017 and served as its Independent Director since March 2004. He served as a Director of Stressgen Biotechnologies Corporation since March 1994 and Life Technologies Corporation from February 1995 to April 30, 2008. He served as a Director at AnaptysBio, Inc. He served as the Chairman of Nventa Biopharmaceuticals Corporation (formerly, Stressgen Biotechnologies Corp.) since April 6, 2006. He served as a Director of Nventa Biopharmaceuticals Corporation since January 2006. He served as a Director of Verenium Corporation from September 1994 to October 2005. He has authored more than 100 publications. In 2006, he was shortlisted by the editors of Nature Biotechnology as a personality making the most significant contribution to biotech in the past decade He is named inventor of over 100 issued patents and several hundred pending patents. He is the recipient of numerous other awards, including an international Best-of-the-Best award from the Young President Organization (2010), American Chemical Society’s Henry F. Whalen, Jr. Award for Business Development (2004) and the Adaptive Business Leaders’ Innovations in HealthCare Gold Award (2003). He received San Diego’s 2001 Ernst & Young Entrepreneur of the Year Award in Health Sciences and was the recipient of two first place awards granted by UCSD’s Connect Innovative Product Program. He received his PhD/MD in Biochemistry from Case Western Reserve University in Cleveland, Ohio and his B.A. with honors in Chemistry from Taylor University in Upland, Indiana.
Positions
- Company NameBioAtla, Inc.Stock CodeBCABPositionCo-Founder, CEO & ChairmanColleagues
- CJChristian J. VasquezCFO & Corporate Secretary
- SMSusie MelodySenior Vice President of Human Resources
- CCCathy ChangSenior Vice President of Research & Development
- GFGerhard FreySenior Vice President of Technology Development
- LSLawrence SteinmanLead Independent Director
- MAMary Ann GrayIndependent Director
- SSSylvia S. McBrinnIndependent Director
- JPJames Patrick AllisonAdvisor
